Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
260 studies found for:    Lymphoma AND (women OR woman OR female)
Show Display Options
Rank Status Study
21 Terminated Breast-Sparing Proton Therapy for Hodgkin's Disease
Condition: Hodgkins Disease
Intervention: Radiation: Proton
22 Completed Efficiency of Gonadotropin-releasing Hormone (GnRH) Agonist in Preventing Chemotherapy Induced Ovarian Failure
Conditions: Fertility Preservation;   Alkylating Agents;   Lymphoma
Interventions: Drug: Triptorelin;   Drug: Norethisterone acetate
23 Terminated
Has Results
Intensive Chemotherapy and Rituximab in the Treatment of Burkitt Lymphoma
Conditions: Burkitt Lymphoma;   Non-Hodgkins Lymphoma;   Atypical Burkitt Lymphoma
Interventions: Drug: Rituximab;   Drug: Cyclophosphamide;   Drug: Doxorubicin;   Drug: Vincristine;   Drug: Methotrexate;   Drug: Leucovorin;   Drug: Ifosfamide;   Drug: Etoposide;   Drug: Cytarabine;   Drug: Mesna
24 Completed Psychosocial Impact of Cancer-Related Female Infertility
Conditions: Hodgkin's Disease;   Cervical Cancer;   Breast Cancer;   Lymphoma
Intervention: Behavioral: Telephone Survey
25 Completed Gleevec in Relapsed/Refractory T Cell Non-Hodgkin's Lymphoma
Condition: T Cell Non-Hodgkin Lymphoma
Intervention: Drug: Imatinib mesylate
26 Recruiting The Effect of Human Placental Explants and Pregnant Women Sera on Cancer Cells
Condition: Cancer
Intervention:
27 Active, not recruiting Rituximab/Bendamustine + Rituximab/Cytarabine for Mantle Cell Lymphoma
Condition: Mantle Cell Lymphoma
Interventions: Drug: Rituximab;   Drug: Bendamustine;   Drug: Cytarabine
28 Completed Clinical Trial of Vitamin D3 to Reduce Cancer Risk in Postmenopausal Women
Condition: Cancer
Interventions: Dietary Supplement: Vitamin D;   Dietary Supplement: Calcium
29 Terminated
Has Results
Vitamin D for Women at Increased Risk of Developing Ovarian, Fallopian, or Primary Peritoneal Cancer
Conditions: Ovarian Cancer;   Fallopian Tube Cancer;   Primary Peritoneal Cancer
Interventions: Dietary Supplement: Arm A: Vitamin D3 Group;   Dietary Supplement: Placebo
30 Terminated Ph II CHOP+Velcade in Mediastinal LBCL
Condition: Non-Hodgkin's Lymphoma
Interventions: Drug: bortezomib;   Drug: Rituximab;   Drug: Cyclophosphamide;   Drug: Doxorubicin;   Drug: Vincristine;   Drug: Prednisone;   Radiation: Radiation therapy
31 Active, not recruiting A Prospective Cohort Study of Occupational Exposures and Cancer Risk Among Women
Conditions: Lung Cancer;   Non-Hodgkin Lymphoma;   Breast Cancer;   Stomach Cancer;   Brain Cancer
Intervention:
32 Active, not recruiting High Dose Rituximab for Initial Treatment of Indolent B-Cell Lymphomas
Conditions: B-cell Lymphoma;   Indolent B-cell Lymphoma
Intervention: Drug: rituximab
33 Completed Oral Clofarabine for Relapsed/Refractory Non-Hodgkin Lymphoma
Conditions: Follicular Lymphoma;   Marginal Zone Lymphoma;   Mantle Cell Lymphoma;   Small Lymphocytic Lymphoma;   Lymphoplasmacytic Lymphoma;   Low Grade B-cell Lymphoma, Not Otherwise Specified;   Diffuse Large B-cell Lymphoma;   Peripheral T-cell Lymphoma;   Angioimmunoblastic T-cell Lymphoma;   Anaplastic Large-cell Lymphoma
Intervention: Drug: Clofarabine
34 Recruiting Cardiac Fibrosis by CMR in Patients With Cancer
Condition: Lymphoma
Intervention: Device: Cardiac Magnetic Resonance Scan
35 Completed
Has Results
Tacrolimus/Sirolimus/Methotrexate Versus Tacrolimus/Methotrexate or Cyclosporine/Mycophenolate Mofetil for GVHD Prophylaxis After Reduced Intensity Allogeneic Stem Cell Transplantation for Patients With Lymphoma
Conditions: Non-hodgkin Lymphoma;   Hodgkin Lymphoma
Interventions: Drug: Sirolimus;   Drug: Methotrexate;   Drug: Tacrolimus;   Drug: Cyclosporine;   Drug: MMF
36 Terminated Assessment and Tracking of Long-term Alefacept Safety
Condition: Psoriasis
Intervention: Drug: Alefacept exposure
37 Completed Cell Lines From High-Risk Breast Tissue
Condition: Healthy
Intervention:
38 Recruiting Pyrimethamine for the Treatment of Relapsed Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Conditions: Chronic Lymphocytic Leukemia;   Small Lymphocytic Leukemia
Intervention: Drug: pyrimethamine
39 Withdrawn Ovarian Damage in Young Premenopausal Women Undergoing Chemotherapy for Cancer
Conditions: Leukemia;   Long-term Effects Secondary to Cancer Therapy in Adults;   Long-term Effects Secondary to Cancer Therapy in Children;   Lymphoma;   Sexual Dysfunction and Infertility;   Sexuality and Reproductive Issues;   Unspecified Adult Solid Tumor, Protocol Specific;   Unspecified Childhood Solid Tumor, Protocol Specific
Interventions: Other: laboratory biomarker analysis;   Procedure: fertility assessment and management;   Procedure: management of therapy complications;   Procedure: ultrasound imaging
40 Terminated CHOP-Rituximab Augmented With GM-CSF in Patients With Previously Untreated Diffuse Large B Cell Non-Hodgkin's Lymphoma
Conditions: Lymphoma, Non-Hodgkin;   Lymphoma, B-Cell;   Lymphoma, Diffuse
Interventions: Drug: GM-CSF;   Drug: CHOP;   Drug: Rituximab

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.